These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23907094)

  • 1. Androgen receptor activation by polychlorinated biphenyls: epigenetic effects mediated by the histone demethylase Jarid1b.
    Casati L; Sendra R; Poletti A; Negri-Cesi P; Celotti F
    Epigenetics; 2013 Oct; 8(10):1061-8. PubMed ID: 23907094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polychlorinated biphenyls affect histone modification pattern in early development of rats: a role for androgen receptor-dependent modulation?
    Casati L; Sendra R; Colciago A; Negri-Cesi P; Berdasco M; Esteller M; Celotti F
    Epigenomics; 2012 Feb; 4(1):101-12. PubMed ID: 22332662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.
    Mitra D; Das PM; Huynh FC; Jones FE
    J Biol Chem; 2011 Nov; 286(47):40531-5. PubMed ID: 21969366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer.
    Xiang Y; Zhu Z; Han G; Ye X; Xu B; Peng Z; Ma Y; Yu Y; Lin H; Chen AP; Chen CD
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19226-31. PubMed ID: 18048344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.
    Wang H; Song C; Ding Y; Pan X; Ge Z; Tan BH; Gowda C; Sachdev M; Muthusami S; Ouyang H; Lai L; Francis OL; Morris CL; Abdel-Azim H; Dorsam G; Xiang M; Payne KJ; Dovat S
    J Biol Chem; 2016 Feb; 291(8):4004-18. PubMed ID: 26655717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination.
    Lu W; Liu S; Li B; Xie Y; Adhiambo C; Yang Q; Ballard BR; Nakayama KI; Matusik RJ; Chen Z
    Oncotarget; 2015 Jan; 6(2):771-88. PubMed ID: 25596733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jarid1b promotes epidermal differentiation by mediating the repression of Ship1 and activation of the AKT/Ovol1 pathway.
    Sun X; Li Z; Niu Y; Zhao L; Huang Y; Li Q; Zhang S; Chen T; Fu T; Yang T; An X; Jiang Y; Zhang J
    Cell Prolif; 2019 Sep; 52(5):e12638. PubMed ID: 31152465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JARID1B represses the osteogenic potential of human periodontal ligament mesenchymal cells.
    Ferreira RS; da Silva RA; Feltran GDS; da Silva EP; de Assis RIF; Rovai ES; Zambuzzi WF; Andia DC
    Oral Dis; 2024 Sep; 30(6):3971-3981. PubMed ID: 37994179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone Demethylase JARID1B Is Overexpressed in Osteosarcoma and Upregulates Cyclin D1 Expression via Demethylation of H3K27me3.
    Wang W; Zheng K; Pei Y; Zhang X
    Oncol Res; 2018 Apr; 26(3):373-384. PubMed ID: 28492139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
    Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
    Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10.
    Kim J; Shin S; Subramaniam M; Bruinsma E; Kim TD; Hawse JR; Spelsberg TC; Janknecht R
    Biochem Biophys Res Commun; 2010 Oct; 401(3):412-6. PubMed ID: 20863814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of RBP2-H1 variant of JARID1B in melanoma.
    Kuźbicki Ł; Lange D; Stanek-Widera A; Chwirot BW
    BMC Cancer; 2017 Dec; 17(1):854. PubMed ID: 29246117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone demethylase JARID1B promotes cell proliferation but is downregulated by N-Myc oncoprotein.
    Zhang L; Sokolowski N; Atmadibrata B; Liu T
    Oncol Rep; 2014 Apr; 31(4):1935-9. PubMed ID: 24481781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of JARID1B expression inhibits cell proliferation, induces apoptosis and blocks cell cycle in human acute lymphoblastic leukemia cells.
    Huang YQ; Zou Y; Zheng RJ; Ma XD
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1366-1373. PubMed ID: 29565495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JARID1B deletion induced apoptosis in Jeko-1 and HL-60 cell lines.
    Su H; Ma X; Huang Y; Han H; Zou Y; Huang W
    Int J Clin Exp Pathol; 2015; 8(1):171-83. PubMed ID: 25755704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor.
    Kristensen LH; Nielsen AL; Helgstrand C; Lees M; Cloos P; Kastrup JS; Helin K; Olsen L; Gajhede M
    FEBS J; 2012 Jun; 279(11):1905-14. PubMed ID: 22420752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal Iron Deficiency and Choline Supplementation Interact to Epigenetically Regulate
    Liu SX; Barks AK; Lunos S; Gewirtz JC; Georgieff MK; Tran PV
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.
    Sayegh J; Cao J; Zou MR; Morales A; Blair LP; Norcia M; Hoyer D; Tackett AJ; Merkel JS; Yan Q
    J Biol Chem; 2013 Mar; 288(13):9408-17. PubMed ID: 23408432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-137 inhibits cell proliferation in acute lymphoblastic leukemia by targeting JARID1B.
    Huang Y; Zou Y; Zheng R; Ma X
    Eur J Haematol; 2019 Sep; 103(3):215-224. PubMed ID: 31206203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JARID1B is a luminal lineage-driving oncogene in breast cancer.
    Yamamoto S; Wu Z; Russnes HG; Takagi S; Peluffo G; Vaske C; Zhao X; Moen Vollan HK; Maruyama R; Ekram MB; Sun H; Kim JH; Carver K; Zucca M; Feng J; Almendro V; Bessarabova M; Rueda OM; Nikolsky Y; Caldas C; Liu XS; Polyak K
    Cancer Cell; 2014 Jun; 25(6):762-77. PubMed ID: 24937458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.